Isocitrate dehydrogenase type I mutation as a prognostic factor in glioblastoma and a literature review

Treatment response and prognosis in glioblastoma (GBM) tumours can differ among patients, highlighting the growing relevance of genetic biomarkers to differentiate glioblastoma sub-types. The biomarker isocitrate dehydrogenase (IDH1) is currently receiving considerable attention. The objective of th...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Neurocirugía (Asturias, Spain) Spain), 2015-11, Vol.26 (6), p.276-283
Hauptverfasser:	de Quintana-Schmidt, Cristian, Alvarez-Holzapfel, María Jesús, Nomdedeu-Guinot, Josep, Bague-Rosell, Silvia, Gallego-Rubio, Oscar, Leidinger, Andreas, Salgado-Lopez, Laura, Molet-Teixidó, Joan
Format:	Artikel
Sprache:	spa
Schlagworte:	Adult Aged Aged, 80 and over Brain Neoplasms - genetics Female Glioblastoma - genetics Humans Isocitrate Dehydrogenase - genetics Male Middle Aged Mutation Prognosis Retrospective Studies Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!